Pages that link to "Q35054958"
Jump to navigation
Jump to search
The following pages link to Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men (Q35054958):
Displaying 50 items.
- Insights on common vaccinations in HIV-infection: efficacy and safety (Q26770665) (← links)
- Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals (Q26825257) (← links)
- Non-AIDS-defining cancers (Q26826855) (← links)
- The rising challenge of non-AIDS-defining cancers in HIV-infected patients (Q26861496) (← links)
- Screening guidelines for non-AIDS defining cancers in HIV-infected individuals (Q27021899) (← links)
- Safety of human papillomavirus vaccines: a review (Q28082119) (← links)
- HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel (Q28244216) (← links)
- Anal dysplasia in HIV-infected women: a commentary on the field (Q30252055) (← links)
- Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States (Q33166996) (← links)
- Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM) (Q33916553) (← links)
- Vaccination in HIV-infected adults (Q33980764) (← links)
- Update on opportunistic infections in the era of effective antiretroviral therapy (Q34085853) (← links)
- Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the (Q34212799) (← links)
- Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. (Q34354553) (← links)
- 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host (Q34390072) (← links)
- Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America (Q34635523) (← links)
- Prevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with men (Q34873067) (← links)
- Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women (Q35008398) (← links)
- Human papilloma virus vaccines: Current scenario (Q35366075) (← links)
- Anal Human Papillomavirus Genotyping among HIV-Positive Men Who Have Sex with Men in Xi'an, China (Q35553220) (← links)
- Prevalence of Anal Human Papillomavirus Infection and Risk Factors among HIV-positive Patients in Tokyo, Japan (Q35773936) (← links)
- Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients (Q36093327) (← links)
- A review of clinical trials of human papillomavirus prophylactic vaccines (Q36286303) (← links)
- HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011 (Q36368353) (← links)
- Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis (Q36399193) (← links)
- Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study (Q36459660) (← links)
- Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children (Q36486823) (← links)
- Cancer prevention in HIV-infected populations (Q36680086) (← links)
- Impact of the HIV epidemic on the incidence rates of anal cancer in the United States (Q36727400) (← links)
- The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer (Q36788317) (← links)
- High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine. (Q36911916) (← links)
- The role of viral co-infection in HIV-associated non-AIDS-related cancers (Q36960884) (← links)
- Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults (Q36977831) (← links)
- Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012. (Q37047999) (← links)
- Prophylactic HPV vaccination and anal cancer (Q37135065) (← links)
- Human Papillomavirus (HPV) Infections and the Importance of HPV Vaccination (Q37155765) (← links)
- Role and uptake of human papillomavirus vaccine in adolescent health in the United States (Q37244355) (← links)
- Anal cancer and cervical cancer screening: Key differences (Q37841421) (← links)
- Human Papillomavirus Vaccination in Males: The State of the Science (Q37848732) (← links)
- Vaccination to protect against infection of the female reproductive tract. (Q37849708) (← links)
- Human papillomavirus, cancer and vaccination (Q37868878) (← links)
- Immunization in the adult immunocompromised host (Q37881239) (← links)
- Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact (Q37912228) (← links)
- Clinical trials of human papillomavirus vaccines and beyond (Q38111962) (← links)
- Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults (Q38134426) (← links)
- Colorectal and anal cancer in HIV/AIDS patients: a comprehensive review (Q38186139) (← links)
- HPV and anal cancer in HIV-infected individuals: a review (Q38225836) (← links)
- Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts (Q38229304) (← links)
- Vaccinating the inflammatory bowel disease patient (Q38243693) (← links)
- Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine (Q38380284) (← links)